Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Open accessThe DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel disease (IBD) is a chronic complex inflammatory gut pathological condition, examples of which include Crohn’s disease (CD) and ulcerative colitis (UC), which is associated with significant morbidity. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is considered a novel factor involved in the pathogenesis of IBD. The gut microbiota acts as a metabolic organ and contributes to human health by performing various physiological functions; deviation in the gut flora composition is involved in various disease pathologies, including IBD. This review aims to summarize the current knowledge of gut microbiota alteration in IBD and how this contributes to intestinal inflammation, as well as explore the potential role of gut microbiota-based treatment approaches for the prevention and treatment of IBD. The current literature has clearly demonstrated a perturbation of the gut microbiota in IBD patients and mice colitis models, but a clear causal link of cause and effect has not yet been presented. In addition, gut microbiota-based therapeutic approaches have also shown good evidence of their effects in the amelioration of colitis in animal models (mice) and IBD patients, which indicates that gut flora might be a new promising therapeutic target for the treatment of IBD. However, insufficient data and confusing results from previous studies have led to a failure to define a core microbiome associated with IBD and the hidden mechanism of pathogenesis, which suggests that well-designed randomized control trials and mouse models are required for further research. In addition, a better understanding of this ecosystem will also determine the role of prebiotics and probiotics as therapeutic agents in the management of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in sex hormones levels may lead to microbial dysbiosis which has been previously implicated in IBD and its symptom severity.(40)”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 3×
“25% (fewer) of the mucosal microbial genes of healthy individuals [25].”
BackgroundInfluentialChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087 · cited 1×
“The highest incidence rate has been recorded in developed countries, such as North America, Europe, Australia, and New Zealand [6], while recently, IBD has been gradually becoming more common in developing areas such as Asia and South America, and in developing countries such as including Brazil, South Korea, and Chin…”
BackgroundAssociation of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 2×
“The NOD2 (nucleotide-binding oligomerization domain containing protein 2), a first gene locus, has been reported as a risk locus for Crohn’s disease (CD) [175,176].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“Human Bacteroidetes Firmicutes, Enterobacteriaceae Decrease Increase [163]”
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 1×
“The NOD2 (nucleotide-binding oligomerization domain containing protein 2), a first gene locus, has been reported as a risk locus for Crohn’s disease (CD) [175,176].”
BackgroundDiarrheagenic Escherichia coli
Nataro, J. P., & Kaper, J. B. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.142 · Cited by 5,006 · cited 1×
“Many studies in human IBD patients have reported the commensal bacteria association with the patient’s intestines; for example, an association of adherent/invasive Escherichia coli (AIEC), a normal gut flora of the Enterobacteriaceae group, has been found with CD [121].”
BackgroundMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 1×
“In addition, certain symbiotic gut microbiota members have been reported to have distinct and specific effects on the host immune system, and are considered key to immune homeostasis [31,37,38].”
BackgroundHost–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“Genome-wide association studies (GWAS) have identified more than 160 genetic loci associated with conferring protection from IBD or increased risk to IBD development [172].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Research works printed but not linked: 2
- Zhang, 2007, Wumei pill decoction in the treatment of 72 cases of chronic nonspecific ulcerative colitis, Mod. J. Integr. Tradit. West. Med., 16, 5156
- Yan, 2013, Effect of Astragalus Polysaccharides on Th17/Treg Cytokines and Pulmonary Inflammation in Asthmatic Rats, Chin. Pharmacol. Bull., 29, 1275
Cited by
Items 601–700 of 804
Franzin, M., Lagatolla, C., Forgiarini, S. S., Haag, M., Neef, S. K., Comar, M., Schaeffeler, E., Bellich, B., Bramuzzo, M., Decorti, G., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70089 · Cited by 2
“Bacteria belonging to the Enterobacteriaceae family are abundant in the intestinal microbiota of patients suffering from paediatric IBD, giving rise to a reduced diversity of gut bacterial species, a condition known as dysbiosis (Khan et al., 2019; Lucafo et al., 2020; Sundin et al., 2017).”
Bioinformatics mining and experimental validation of prognostic biomarkers in colorectal cancer
Huang, F., Alshehade, S. A., Zhao, W. G., Li, Z. Y., Fong, J. Y., Okechukwu, P. N., Ng, C. T., Venkatachalam, K., Jeleń, M., Mlodawsak, B. M., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-03301-9 · Cited by 2
“Enrichment analysis was used to determine the candidate genes’ connections to pertinent biochemical metabolic and signal transduction pathways [22].”
Huang, J., Liu, Z., Liu, Y., Liu, Y., Tian, Z. R., Yao, M., Wang, W., & Liu, Z. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157282 · Cited by 2
From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways
Ibgui, S., Lints, D., & Milling, S. W. F. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.108059 · Cited by 2
Prakash, S., Bisht, S., & Jaiswal, V. P. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_10 · Cited by 2
Wang, Q., Zhai, Y., Zhang, Y., Li, Z., Wang, Q., & Liu, S. (2026) · International Dental Journal · doi:10.1016/j.identj.2026.109461 · Cited by 3
Rutgrink, J. M. I., & Velde, A. A. T. (2026) · Immuno · doi:10.3390/immuno6020024 · Cited by 2
“Both human and animal studies consistently demonstrate long-lasting alterations in the gut microbiome of individuals with IBD [25–28].”
Gholam-Mostafaei, F. S., Didari, T., Ramandi, M., Vafaee, R., & Rostami‐Nejad, M. (2021) · Gastroenterology and hepatology from bed to bench. · Cited by 4
Zhou, H., Astore, C., & Skolnick, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-25412-x · Cited by 4
“Furthermore, gut microbiota play a major role in the pathogenesis of IBD as it may promote inflammation 41 .”
BackgroundHajra, D., Kirthivasan, N., & Chakravortty, D. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00554 · Cited by 2
The Prevalence of extraintestinal manifestations in Inflammatory Bowel Disease
Madej, A., Senat, H., Grabowska, P., Bolla, P., Senat, A., & Marczyńska, Z. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.58.007 · Cited by 2
Dietary Strategies for Alleviating Inflammation and Metabolic Disorders: A Narrative Review
Setiawan, B., & Ernawati, E. (2023) · Calvaria Medical Journal. · doi:10.30742/cmj.v1i2.23 · Cited by 3
“As previously reviewed, dysbiosis is recognized as a critical factor in both chronic inflammatory and metabolic dysfunction (Khan et al., 2019).”
BackgroundPacuta, I., Gancarčíková, S., Lauko, S., Hajdučková, V., Janíčko, M., Demečková, V., Rynikova, M., Adamkova, P., Mudroňová, D., Ambro, Ľ., et al. (2024) · Applied Sciences · doi:10.3390/app14114856 · Cited by 3
Parnian-Khajehdizaj, N., Mainer-Pardos, E., Machek, S. B., & Nobarı, H. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/2610415 · Cited by 3
Mi, R., Li, X., Li, Y., & Du, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317891 · Cited by 2
“The gut microbiota composition of mice before administration of TSFP was similar to previous reports, and the observed bacteria were regarded as the indigenous microorganisms in the gut of mice [45].”
Wang, Q., Im, Y., Park, J., Lee, H. L., Ryu, D. G., & Kim, H. (2025) · Foods · doi:10.3390/foods14050714 · Cited by 2
“Although it is uncertain whether intestinal disturbances cause or are a consequence of IBD, there is a clear connection between gut microbiota dysfunction, dysbiosis, and IBD [21].”
InfluentialEmbodied Data: Gleaning Narratives of Living with Chronic Gut Diseases to Guide the Design Process
Demir, A. D. (2025) · Experiential Knowledge Special Interest Group Conference (EKSIG) · doi:10.21606/eksig2025.109 · Cited by 2
Climate Change and the Microbial Shift: Unveiling Hidden Risks for Cancer Progression
Gopalakrishnan, V., Saravanan, V., Mahendran, M. I. M. S., Boopathy, V., Vaithianathan, R., & Srinivasan, S. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-25-0565 · Cited by 2
Zaichenko, K., Gavryliuk, V. G., Кленіна, І. А., Sklyar, T. V., Соколова, И. Е., Tatarchuk, О. М., & Vishnarevska, N. S. (2020) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs05.03.273 · Cited by 2
“The current believing is that there is no welldefined evidence to prove that Clostridium difficile could be considered as a causing factor in IBD, however, its frequent association with IBD patients more likely shows that Clostridium difficile infection is secondary, and contributes to exacerbation in IBD pathogenesis…”
BackgroundInfluentialSauer, A. K., Dooley, L., Vaughan, A., & Grabrucker, A. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822822-7.00007-7 · Cited by 3
Next-generation Probiotics, Parabiotics, and Postbiotics
Cho, K.-K., Lee, S., In-Soon, C., & Sang-Won, L. (2021) · JoLS Journal of Life Sciences · doi:10.5352/jls.2021.31.6.595 · Cited by 2
Current Topics of the Mechanism of Intestinal Fibrosis in Crohn’s Disease
Honzawa, Y., Yamamoto, S., Okabe, M., Seno, H., & Nakase, H. (2021) · Immuno · doi:10.3390/immuno1040040 · Cited by 2
Blagov, A. V., Zhigmitova, E. B., Sazonova, M. A., Михалева, Л. М., Kalmykov, V. A., Shakhpazyan, N. K., Orekhova, V. A., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095141 · Cited by 2
Alexandru, B. A., Rat, L. A., Moldovan, A. F., MIHANCEA, P., & Mariș, L. (2022) · Medicina · doi:10.3390/medicina58060763 · Cited by 3
Yin, J., Li, D., Zheng, T., Wang, X., Hu, B., & Wang, P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.991818 · Cited by 2
Peng, C.-R., Wang, Y., Wang, S.-L., Wu, S.-M., Li, J., Cheng, R., He, F., & Shen, X. (2022) · PubMed Central · doi:10.12182/20220960104 · Cited by 2
Translation of Immunomodulatory Effects of Probiotics into Clinical Practice
Ryan, J. C., Narasimha, S. V., Pattison, R., Zackria, R., Ghobrial, Y., Basit, S. A., Ammar, T. A. R. A., Jayaraman, V., Stone, C. D., & Shih, D. Q. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109864 · Cited by 3
Sabbagh, E. E., Shaker, O. G., Kassem, A. M., & Khairy, A. M. (2023) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2023.199933.7727 · Cited by 2
Hammad, D. B. M., Alhamad, O. A., Khzal, A. M. O., & Alameedy, F. M. M. (2023) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.37.84 · Cited by 2
Ji, C., Huang, Y., Xie, W., Zhu, Y., Qin, J., Guo, S., Xiao, H., Fan, W., & Tang, Z. (2024) · Food Frontiers · doi:10.1002/fft2.400 · Cited by 2
COVID-19, МИКРОБИОМ КИШЕЧНИКА И НАТУРАЛЬНЫЕ ПРОДУКТЫ ПИТАНИЯ (ОБЗОР)
Indershiyev, V., Тасбулатовна, Е. Л., Мусаев, А. Т., Мамбетова, И. З., Мусаев, А. А., РАХИМБАЕВА, Ж. Б., & Джунусова, Ж. С. (2023) · Фтизиопульмонология · doi:10.26212/2227-1937.2023.12.56.002 · Cited by 2
Porro, C., Benameur, T., Cianciulli, A., Vacca, M., Chiarini, M., Angelis, M. D., & Panaro, M. A. (2023) · Preprints.org · doi:10.20944/preprints202311.0822.v1 · Cited by 2
The Interplay Between Use of Biological Therapies, Psychological State, and the Microbiome in IBD
Tavakoli, P., Vollmer-Conna, U. S., Hadži-Pavlović, D., Vázquez-Campos, X., & Grimm, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.788992 · Cited by 1
Saberes ancestrais como promoção à saúde física e mental: um olhar agroecológico
Barbosa, F. S. (2023) · ODEERE · doi:10.22481/odeere.v8i3.13872 · Cited by 1
Postbiotics—A Revolution Engineering Symbiotics ofInanimate microorganisms and their components
ółkiewicz, J. Z. ̇., Marzec, A., & Wong, J. P. (2024) · International Journal of Scientific Research and Management (IJSRM) · doi:10.18535/ijsrm/v12i05.mp03 · Cited by 2
“Postbiotics may also be useful in the prevention and treatment of SARS-CoV-2 infection, as the structure and metabolic activity of the intestinal microbiome may be related to the occurrence of biomarkers predicting the severe coronavirus disease 2019 (COVID-19) course [106].”
BackgroundQiu, H., Liu, M., Wei, Y., Li, J., Zhou, S. L., & Mo, X. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303287122240429092014 · Cited by 1
Zhou, N., Wu, N., Yao, Y., Chen, S., Xu, M., Yin, Z., Zhao, Y. M., & Tu, Y. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250136 · Cited by 1
Siam, M. H. B., Mondol, S. M., Shakil, S. K., Islam, M. R., Islam, I., Saha, O., Amiruzzaman, Datta, R., Ahmed, T., Gomes, D. J., et al. (2024) · Microbiology Resource Announcements · doi:10.1128/mra.00738-24 · Cited by 1
“…bowel disease (IBD) is a chronic gastrointestinal illness characterized by abdominal cramps, persistent diarrhea, bloody stool, and weight loss, becoming increasingly prevalent in newly industrialized and developing countries like Bangladesh due to the adoption of a western lifestyle (1).”
Faecal transplantation: the good, the bad and the ugly
Sin, H. C. L., & Haifer, C. (2024) · Internal Medicine Journal · doi:10.1111/imj.16559 · Cited by 1
Distinguishing Crohn’s Disease From Non–Crohn’s Ileitis: A Gut Microbiome–Based Approach
Raghunathan, N., Joshi, V., Mekala, D., Patel, R., Godbole, S., Talukdar, R., Reddy, D. N., & Banerjee, R. (2025) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/8253763 · Cited by 1
“Several research groups have established the close relation of gut dysbiosis in CD with pathogenesis and identi fi ed bacteria that are abundant or depleted during active disease [10, 12 – 14, 26, 27].”
López-Carrasquillo, J., Ramos-Plaza, V. Y., Cruz, M. L., Rodriguez-Morales, B. M., Sánchez, R., López, P., Chompré, G., & Appleyard, C. B. (2025) · Nutrients · doi:10.3390/nu17172719 · Cited by 1
“Disruption of the gut microbial community is commonly recognized as a central contributor to the pathogenesis of IBD [4,53].”
Emotional Disturbances and Crohn's Disease
Lastretti, M., D’Aleo, E., Pica, R., Nitto, D. D., Carta, M. G., & Faa, G. (2025) · Clinical Practice and Epidemiology in Mental Health · doi:10.2174/0117450179410096250926135151 · Cited by 1
Zhao, C., Lao, J., Cao, J., Yang, Y., Liu, C., & Tang, F. (2025) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70173 · Cited by 1
Decoding the Gut Microbiota: Mechanisms of Host-Microbe Interactions and Inflammatory Pathologies
Richie, T. G., & Lee, S. T. M. (2025) · Digestion · doi:10.1159/000549457 · Cited by 1
Gut Microbiome Variability in Pediatric Patients With Inflammatory Bowel Disease
Maeder, K., & Nguyen, M. (2025) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/9002193 · Cited by 1
Chen, Z., Cheng, Q., Zhang, X., Sheng, Z., Shi, L., & Zhang, Y. (2026) · AMB Express · doi:10.1186/s13568-025-02003-3 · Cited by 1
“Inflammatory bowel disease (IBD) is a chronic gastrointestinal inflammatory disorder characterized by a steadily increasing incidence in recent years, rendering it a globally concerning health issue (Khan et al. 2019).”
Zhong, W., Xu, L., Zhang, X., Deng, X., & Shen, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114652 · Cited by 2
Harnessing Microbiome Therapy to Treat Metabolic Syndrome
Jnainati, M. A., Govindarajan, A., Tyagi, S., Iltaf, M., Jnainati, J. A., Ayoub, M., & Shadab, H. A. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.11.015 · Cited by 1
Wetthasinghe, L., Ng, H. F., Chew, K. S., Ranai, N. M., Ngeow, Y. F., & Lee, W. J. (2026) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.70307 · Cited by 1
Đogatović, K., Vučićević, K. M., Kovačević, M., Ćulafić, M., Miljković, B., & Kovačević, S. V. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062172 · Cited by 1
“An imbalance in gut microbiota (dysbiosis) further fuels inflammation, leading to chronic tissue damage and complications [5].”
Implementing microbiome analysis in clinical practice: overcoming challenges
Kumar, M., Kumar, S., Kumar, R., Singh, R., Bhoi, B., Kumar, G., & Gupta, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00044-3 · Cited by 1
Adly, R. S., Mohammed, A. H., Wadie, M., Bedier, A. I., & Teima, S. M. (2026) · Pakistan Heart Journal · doi:10.47144/phj.v59i3.3188 · Cited by 1
Al‐Massri, K. F. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108707 · Cited by 1
Faecal transplantation and Clostridioides difficile infection
Knežević, D., & Petković, M. R. (2021) · Scripta Medica · doi:10.5937/scriptamed52-32752 · Cited by 1
Beneficial Effect of a Juice-Based Probiotic for Colon Health
Robins, H. F., & Kamarei, A. R. (2021) · Journal of Gastroenterology Research · doi:10.36959/621/619 · Cited by 1
Yousof, S. M., Tanvir, I., Kolieb, E., & Atta, R. (2021) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_9_21 · Cited by 3
“Thereby, the disturbances in the lungs by inflammations could affect the gut from one side, and the passage of endotoxins or metabolites of microbes that harbor the gut to the blood could affect the lung function from the other side.[8-10] Many studies have reported that patients with COVID-19 displayed The COVID-19 p…”
BackgroundGastrointestinal Tract and COVID-19: Insights Into the Role of Gut Microbiome
Lelo, A. P., & Zinedine, A. (2021) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-8225-1.ch008 · Cited by 1
Stepanov, Y. М., Tіtova, M. V., & Nedzvetska, N. V. (2021) · GASTROENTEROLOGY · doi:10.22141/2308-2097.55.3.2021.241586 · Cited by 1
“This is due to the fact that the most dominant etiological hypothesis indicates an immune response to the altered microbiota in a genetically predisposed host [3, 4].”
BackgroundA Narrative Review of the Gut Microbiota and Its Association with Diseases
Nashin, D. (2022) · Science Insights · doi:10.15354/si.22.re016 · Cited by 1
“treatment of gut flora will become a focal point (34).”
BackgroundCOVID-19 Hastalığında Probiyotiklerin Rolü, Önemi ve Kullanımı
Özdemır, Ö., & Ayşegül, P. A. L. A. (2022) · Sakarya Medical Journal · doi:10.31832/smj.933390 · Cited by 1
Stepanov, Y. М., Stoikevych, M. V., Кленіна, І. А., & Tatarchuk, О. М. (2022) · GASTROENTEROLOGY · doi:10.22141/2308-2097.56.2.2022.495 · Cited by 1
Microorganisms in Pathogenesis and Management of Psoriasis Arthritis (PsA)
Dobrică, E.-C., Banciu, L. M., Voiculescu, V.-M., & Maria, G. A. (2022) · Springer eBooks · doi:10.1007/978-981-19-1946-6_19 · Cited by 1
Microbiota and its relationship with Inflammatory Bowel Diseases: An overview
Al-Judaibi, A. A., Al-Hebshi, B. M., & Al-Judaibi, E. A. (2023) · Microbial Biosystems · doi:10.21608/mb.2023.211583.1072 · Cited by 1
“The genetic susceptibility of individuals to various conditions such as antibiotics is influenced by their surroundings as well as by the relationship between their intestinal microbiota and their immune systems (Caviglia et al., 2019; Khan et al., 2019).”
BackgroundTHE ROLE OF GUT MICROBIOTA IN IMMUNOMODULATION AND AUTOIMMUNE DISEASES: A COMPREHENSIVE REVIEW
Ali, O. M. (2023) · International Journal of Medical Science and Dental Health · doi:10.55640/ijmsdh-09-12-09 · Cited by 2
Benefits and safety of probiotics in gastrointestinal diseases
Profir, M., Roşu, O. A., Ionescu, R. F., Pavelescu, L. A., & Creţoiu, S. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-824472-2.00011-7 · Cited by 5
Use of FISH‐FLOW as a Method for the Identification and Quantification of Bacterial Populations
Bucheli, J. E. V., Lee, Y., Kim, B., Azevedo, N. F., Azevedo, A. S., Todorov, S. D., Ji, Y., Kang, H., & Holzapfel, W. H. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400494 · Cited by 1
Chen, C.-C., Lin, Y.-A., Liu, K., Huang, C., Shih, C., Lee, Y.-T., Pan, J.-L., & Lee, A.-W. (2024) · Virology Journal · doi:10.1186/s12985-024-02529-1 · Cited by 1
Liu, R., Wang, Y., & Cheng, D. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae667 · Cited by 1
“Compared to healthy individuals, the reduction in the relative abundance of Firmicutes and an elevation in Bacteroidetes have been observed in IBD patients (Khan et al. 2019, Lo Presti et al. 2019, Vuik et al. 2019, Zhang et al. 2022).”
Mishra, S., Sahu, A., Anakha, S., & Choubey, M. (2025) · Springer eBooks · doi:10.1007/978-981-97-9056-2_5 · Cited by 3
Microbiomes in Medicine and Agriculture
ROSENBERG, E. B. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-65317-0_10 · Cited by 2
Ohya, S., Matsui, M., & Kajikuri, J. (2020) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3234 · Cited by 1
Probiotics in Inflammatory Bowel Diseases
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_8 · Cited by 1
Detman, A., Schiro, G., Filip, R., Samborowska, E., Karczmarski, J., Jakubowska, K., Jarmakiewicz-Czaja, S., Williams, A., Hickman, N., Laubitz, D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.29.656803 · Cited by 1
“Analysis of stool samples from CD patients and healthy individuals confirmed the well-recognized decrease in microbial richness and diversity characteristic of CD-associated dysbiosis 1,9,13,23–28 .”
Estimating the causal effect of body mass index on gut microbiota variationPreprint
Hughes, D. A., Corbin, L. J., Proost, S., Wade, K. H., Raes, J., & Timpson, N. J. (2025) · medRxiv · doi:10.1101/2025.08.18.25333926 · Cited by 1
Heuer, H., Schmalowski, D., Abu, O. A., Hoernlein, M., Zimmerling, U., Reinecke, J., Richert‐Pöggeler, K. R., & Babin, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.02.736003 · Cited by 1
Diet and inflammatory bowel disease; a metabolomic approach
Keshteli, A. H. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-47b0-nc90
Genetic Engineering for Revealing Underlying Mechanisms of Inflammatory Bowel Diseases
Roseth, I. A. (2020) · NORA - Norwegian Open Research Archives
Ткач, С. М., Dorofeev, A. E., & Kuzenko, Y. G. (2020) · Modern Gastroenterology · doi:10.30978/mg-2020-4-5
Alshehri, D., Mosli, M. H., & Bahieldin, A. (2020) · Applied Ecology and Environmental Research · doi:10.15666/aeer/1806_82518265
“Dysbiosis in the gut microbiota composition has been linked to many disorders; one of these is IBD (De Musis et al., 2020; Khan et al., 2019; Lavelle and Sokol, 2020).”
BackgroundImmune-Microbiota Crosstalk Underlying Inflammatory Bowel Disease
Xu, C., Mac, Q. D., Jia, Q., & Qiu, P. (2021) · Lecture notes in computer science · doi:10.1007/978-3-030-91415-8_2
Escherichia coli Strains in Patients with Inflammatory Bowel Diseases: A Review
Al-Amrah, H., Alotaibi, H., & Sadiq, N. (2022) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2966
Ulcerative Colitis after Implantation of Radioactive Seeds for Prostate Cancer: A Case Report
李, 彬. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.111012
Avaliação do conhecimento de consumidores sobre os alimentos fontes de prebióticos e probióticos
Santos, A. P. B., Aguiar, T. B. L., Silva, D. H. G., & Vieira, K. H. (2022) · Revista Cereus · doi:10.18605/2175-7275/cereus.v14n2p25-34
Probióticos para el tratamiento de la Colitis Ulcerosa y la Enfermedad de CrohnPreprint
Aliaga, A. C., & Delgado-Diaz, D. J. (2022) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/9cpk3
Gestational Diabetes Mellitus and Its Impact on the Mother- Infant Gut and Breast Milk BacteriomePreprint
Valencia, S., Hernández-Beza, M. J., Powell-Cerda, I., Acosta-Cruz, E., Rodríguez-Castillejos, G., Siller-López, F., & Martínez-Montoya, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1739630/v2
Suciangto, W., & Syahrir, M. (2022) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/2332022241-249
Efficacy of ginsenoside treatment to alleviate anticancer-drug induced mucoenteritis in mice
Kato, D., Jonan, S., Sugahara, R., Otsuki, H., Nakamura, S., & Amagase, K. (2022) · Integrative Physiology · doi:10.33910/2687-1270-2022-3-3-336-347
Gut Microbiome and Diabetes – A Bibliometric and Narrative ReviewPreprint
Mishra, A., Mishra, P., & Mishra, V. (2023) · Preprints.org · doi:10.20944/preprints202306.1578.v1
Veseli, I., Chen, Y. T., Schechter, M. S., et al. (2023) · eLife · doi:10.7554/elife.89862.1.sa1
SHAHID, H., Malik, Z. A., & MALIK, M. (2023) · Biological and Clinical Sciences Research Journal · doi:10.54112/bcsrj.v2023i1.386
He protec but he also attac – Inflammasomes swinging the sword
Kattner, A. A. (2023) · Biomedical Journal · doi:10.1016/j.bj.2023.100663
“Disturbances in its balance may both contribute to and result from intestinal inflammation [14].”
BackgroundMicrobial harmony in peril? Identifying the impact of antibiotics on a healthy animal gut
Pal, S. (2023) · Indian Journal of Animal Health · doi:10.36062/ijah.2023.spl.02423
Metadata
- Authors
- Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C.
- Affiliations
- Lanzhou University (CN)
- Gansu Key Laboratory of Functional Genomics and Molecular Diagnosis, Lanzhou 730000, China
- Corresponding author
- Zhang, Chunjiang
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2019-08-13
- Volume
- 8
- Issue
- 3
- Pages
- 126
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC6789542
- OpenAlex
- W2966933380
- Cited by
- 771
- References
- 267
- Citations by year
- 2026: 43 · 2025: 105 · 2024: 149 · 2023: 134 · 2022: 135 · 2021: 132 · 2020: 66 · 2019: 7
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lanzhou University Institutional Repository (submittedVersion, cc-by-nc-sa)
- Lanzhou University Institutional Repository (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jiangsu Science and Technology Major Project ((No. BA2016036))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, gut microbiota, dysbiosis, Crohn's disease, ulcerative colitis, intestinal inflammation, microbiota-based therapy, probiotics, prebiotics, mouse colitis model, IBD pathogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.